Associate EMAC Instructor application form
NHMRC-grant-for-breakthrough-blood-research-12-Dec-2018
Interventional_Pain_Medicine
Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor Use
Alert update May 2023: Periprocedural diabetic ketoacidosis (DKA) with sodium-glucose co-transporter-2 inhibitor use in people with diabetes.
WBA-information-for-interviewees
Tasmanian Health 22072002
ANZCA-response-to-ANZCOR-guideline-4-Airway-20210127
Tasmanian Health Service NWRH April 2021
DRGA-Media-Release-290921